6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Disease-Specific Regenerative Medicine
Precision approaches are driving innovation in disease-specific regenerative medicine, where therapies are designed to meet the distinct requirements of conditions like Parkinson’s, type 1 diabetes, and osteoarthritis. By targeting disease mechanisms, researchers employ tailored stem cell lines, responsive scaffolds, and signaling molecules to regenerate affected tissues more effectively. Integration of genetic profiling and cellular engineering enables treatments that address not only structural damage but also underlying pathophysiology. Disease-specific regenerative medicine brings personalized medicine closer to reality by aligning molecular pathology with regenerative tools. This targeted approach reduces risks of immune rejection and improves therapeutic efficacy, especially in chronic and degenerative conditions with limited treatment options.
Kunal Mitra
Florida Tech, United States
Nagy Habib
Imperial College London, United Kingdom
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Paige Derr
National Institutes of Health, United States
Aradhana Kasimsetty
National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States
Lisa Martin
University Grenoble Alpes, France
Audrey Cherblanc
Healshape SAS, FranceSubmit your abstract Today
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States